Concepedia

Author

Alison Mbekeani

University of Liverpool

Also Known As

A. J. MBEKEANI, A.J. Mbekeani, Alison J. Mbekeani, Alison Mbekeani, Mbekeani, A.

17

Publications

504

Citations

9

H-Index

16

Concepts

All Affiliations

University of LiverpoolLiverpool School of Tropical MedicineDurham UniversityUniversity of BaghdadImperial College London
AM

About

Alison Mbekeani is an author at University of Liverpool specializing in medicine, drug development, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

186

2

Natural Sciences

3

3

186

3

Biochemistry

3

3

186

4

Chemical Biology

3

3

186

5

Pharmacology

3

3

186

Alison Mbekeani

×

9

Publications

495

Citations

9

H-Index

YearCitations

Generation of quinolone antimalarials targeting the <i>Plasmodium falciparum</i> mitochondrial respiratory chain for the treatment and prophylaxis of malaria

Giancarlo A. Biagini, Nicholas Fisher, Alison E. Shone,

Proceedings of the National Academy of Sciences

2012

156

Identification, Design and Biological Evaluation of Bisaryl Quinolones Targeting <i>Plasmodium falciparum</i> Type II NADH:Quinone Oxidoreductase (PfNDH2)

Chandrakala Pidathala, Richard K. Amewu, Bénédicte Pacorel,

Journal of Medicinal Chemistry

2012

109

Cryopreservation-related loss of antigen-specific IFNγ producing CD4+ T-cells can skew immunogenicity data in vaccine trials: Lessons from a malaria vaccine trial substudy

Tom Ford, Claire Wenden, Alison Mbekeani,

Vaccine

2017

56

Identification, Design and Biological Evaluation of Heterocyclic Quinolones Targeting <i>Plasmodium falciparum</i> Type II NADH:Quinone Oxidoreductase (PfNDH2)

Suet C. Leung, Peter Gibbons, Richard K. Amewu,

Journal of Medicinal Chemistry

2012

54

Complex Interplay between Sphingolipid and Sterol Metabolism Revealed by Perturbations to the Leishmania Metabolome Caused by Miltefosine

Emily G. Armitage, Amjed Qays Ibrahim Alqaisi, Joanna Godzień,

Antimicrobial Agents and Chemotherapy

2018

46

Identification of Novel Antimalarial Chemotypes via Chemoinformatic Compound Selection Methods for a High-Throughput Screening Program against the Novel Malarial Target, PfNDH2: Increasing Hit Rate via Virtual Screening Methods

Raman Sharma, Alexandre S. Lawrenson, Nicholas Fisher,

Journal of Medicinal Chemistry

2012

23

A novel drug for uncomplicated malaria: targeted high throughput screening (HTS) against the type II NADH:ubiquinone oxidoreductase (PfNdh2) of Plasmodium falciparum

Stephen A. Ward, Nicholas Fisher, Alasdair Hill,

Malaria Journal

2010

20

The antifungal Aureobasidin A and an analogue are active against the protozoan parasite<i>Toxoplasma gondii</i>but do not inhibit sphingolipid biosynthesis

Amjed Qays Ibrahim Alqaisi, Alison Mbekeani, M. Bassas Llorens,

Parasitology

2017

17

Mining for natural product antileishmanials in a fungal extract library

Alison Mbekeani, Rebecca Jones, M. Bassas Llorens,

International Journal for Parasitology Drugs and Drug Resistance

2019

14

Page 1